Dr. Andrew A Quon, MD is a Radiologist - Diagnostic Radiology practicing in Stanford, CA
He has not yet shared a personalized biography with Doctor.com.
University | Degree | Focus | Graduated |
---|---|---|---|
University of Texas Southwestern Medical School, Dallas | Medical Degree | 1998 |
Institution | Focus | Year |
---|---|---|
Residency - UCLA School Of Med | Not Specified | |
Residency - Harbor-UCLA Medical Center | Not Specified |
Certification | Cert. Body | Year |
---|---|---|
Nuclear Medicine | Nuclear Medicine | Not Specified |
Publication | Publisher | Title | Published |
---|---|---|---|
Other Publication | CANCER | Impact of positron emission tomography | 2013 |
Other Publication | JOURL OF NUCLEAR MEDICINE | Metabolic Tumor Volume Predicts Disease Progression | 2013 |
Other Publication | Lung cancer | Metabolic imaging metrics correlate with survival | 2012 |
Other Publication | EUROPEAN JOURL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | Initial investigation of F-18-F PET | 2012 |
Other Publication | JOURL OF CARDIAC FAILURE | Dipeptidyl Peptidase 4 Inhibition Increases Myocardial Glucose Uptake in Nonischemic Cardiomyopathy | 2012 |
Other Publication | Jayachandran, P., Pai, R. K., Quon, A., Graves, E., Krakow, T. E., La, | Postchemoradiotherapy Positron Emission Tomography Predicts Pathologic Response | 2012 |
Other Publication | JOURL OF MAGNETIC RESONCE IMAGING | Comparison of MRI and 18F-F PET/CT in patients with patellofemoral pain | 2012 |
Other Publication | Chennupati, S. K., Quon, A., Kamaya, A., Pai, R. K., La, T., Krakow, T | Positron Emission Tomography for Predicting Pathologic Response After Neoadjuvant Chemoradiotherapy | 2012 |
Other Publication | CANCER RESEARCH | Prognostic PET F-18-FDG Uptake Imaging Features Are Associated with Major Oncogenomic Alterations | 2012 |
Other Publication | RADIOLOGY | Non-Small Cell Lung Cancer | 2012 |
Other Publication | JOURL OF ORTHOPAEDIC RESEARCH | Patients with patellofemoral pain exhibit elevated bone metabolic activity at the patellofemoral | 2012 |
Other Publication | CLINICAL LUNG CANCER | Metabolic Tumor Volume is an Independent Prognostic Factor in Patients Treated Definitively for Non | 2012 |
Other Publication | SPINE | Pattern of 18F-FDG Uptake in the Spil Cord in Patients With Non-Central Nervous System Maligncy | 2011 |
Other Publication | INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | POSTRADIATION METABOLIC TUMOR VOLUME PREDICTS OUTCOME IN HEAD-AND-NECK CANCER | 2011 |
Other Publication | JOURL OF THORACIC ONCOLOGY | Tumor Volume as a Potential Imaging-Based Risk | 2011 |
Other Publication | NUCLEAR MEDICINE COMMUNICATIONS | F-18-5-fluorouracil dymic positron emission tomography | 2011 |
Other Publication | JOURL OF THE AMERICAN COLLEGE OF CARDIOLOGY | Rosiglitazone Increases Myocardial Glucose Metabolism in Insulin-Resistant Cardiomyopathy | 2010 |
Other Publication | BLOOD | Interim positron emission tomography scans in diffuse large B-cell lymphoma | 2010 |
Other Publication | EUROPEAN JOURL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | Efficacy of F-18-FDG PET/CT in the evaluation of patients with recurrent cervical carcinoma | 2009 |
Other Publication | EUROPEAN JOURL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | Focal fat mimicking multiple hepatic metastases on FDG PET/CT imaging | 2009 |
Other Publication | INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | METABOLIC TUMOR VOLUME PREDICTS FOR RECURRENCE AND DEATH IN HEAD-AND-NECK CANCER | 2009 |
Other Publication | MOLECULAR IMAGING AND BIOLOGY | Simulations of Virtual PET/CT 3-D Bronchoscopy Imaging Using a Physical Porcine Lung-Heart Phantom | 2009 |
Other Publication | CLINICAL NUCLEAR MEDICINE | Detection of Solitary Humeral Metastasis From Pancreatic Adenocarcinoma With F-18 FDG PET/CT | 2009 |
Other Publication | JOURL OF NUCLEAR MEDICINE | Novel Strategy for a Cocktail F-18-Fluoride and F-18-FDG PET | 2009 |
Other Publication | CANCER | Stereotactic Radiotherapy for Unresectable Adenocarcinoma of the Pancreas | 2009 |
Other Publication | RADIOLOGIC CLINICS OF NORTH AMERICA | Positron Emission Tomography/Computed Tomography: The Current Technology and Applications | 2009 |
Other Publication | CLINICAL NUCLEAR MEDICINE | PET/CT Imaging of Gastrointestil Stromal Tumor | 2008 |
Other Publication | NUCLEAR MEDICINE COMMUNICATIONS | F-18-FDG PET/CT evaluation of patients with ovarian carcinoma | 2008 |
Other Publication | INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | Gemcitabine chemotherapy | 2008 |
Other Publication | HELLENIC JOURL OF NUCLEAR MEDICINE | F-18-FDG-PET/CT evaluation of response to treatment in lymphoma | 2008 |
Other Publication | EUROPEAN JOURL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | Initial evaluation of F-18-fluorothymidine (FLT) PET/CT scanning for primary pancreatic cancer | 2008 |
Other Publication | MOLECULAR IMAGING AND BIOLOGY | I-123 MIBG mapping with intraoperative gamma probe for recurrent neuroblastoma | 2008 |
Other Publication | CLINICAL NUCLEAR MEDICINE | FDG PET/CT detection of a gossypiboma in the neck | 2007 |
Other Publication | RADIOLOGY | Molecular imaging techniques in body imaging | 2007 |
Other Publication | INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | Metabolic tumor burden predicts for disease progression and death in lung cancer | 2007 |
Other Publication | JOURL OF CLINICAL ONCOLOGY | Impact of positive positron emission tomography on prediction of freedom from progression after | 2007 |
Other Publication | NUCLEAR MEDICINE COMMUNICATIONS | Clinical value of including the head and lower extremities in F-18-FDG PET | 2007 |
Other Publication | CLINICAL NUCLEAR MEDICINE | No apparent alteration of F-18 FDG biodistribution when injected shortly after insulin glargine | 2007 |
Other Publication | SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA | Advances in metabolic imaging for surgical oncology | 2007 |
Other Publication | TECHNOLOGY IN CANCER RESEARCH & TREATMENT | RT_Image: An open-source tool for investigating PET in radiation oncology | 2007 |
Other Publication | RADIOLOGY | Detection of bone metastases: Assessment of integrated FDG PET/CT imaging | 2007 |
Other Publication | TECHNOLOGY IN CANCER RESEARCH & TREATMENT | Impact of integrated PET/CT on variability of target volume delineation in rectal cancer | 2007 |
Other Publication | MOLECULAR IMAGING AND BIOLOGY | 2-deoxy-2-[F-18]fluoro-D-glucose positron emission tomography | 2007 |
Other Publication | JOURL OF NUCLEAR MEDICINE | Clinical role of F-18-FDG PET/CT | 2007 |
Other Publication | CLINICAL NUCLEAR MEDICINE | F-18FDG PET/CT evaluation of osseous and soft tissue sarcomas | 2006 |
Other Publication | Ultrasound quarterly | Sonography of the abnormal parathyroid gland. | 2006 |
Other Publication | CLINICAL NUCLEAR MEDICINE | F-18 fluorodeoxyglucose PET/CT | 2006 |
Other Publication | JOURL OF NUCLEAR MEDICINE | Flying through and flying around a PET | 2006 |
Other Publication | MOLECULAR IMAGING AND BIOLOGY | Merkel cell carcinoma | 2006 |
Other Publication | ARCHIVES OF DERMATOLOGY | Staging accuracy in mycosis fungoides | 2006 |
Other Publication | ANLS OF NUCLEAR MEDICINE | Diagnosis of aseptic deep venous thrombosis of the upper extremity | 2006 |
Other Publication | MOLECULAR IMAGING AND BIOLOGY | Performance of 2-deoxy-2-[F-18]fluoro-D-glucose positron emission tomography and integrated PET | 2005 |
Other Publication | JOURL OF CLINICAL ONCOLOGY | FDG-PET and beyond: Molecular breast cancer imaging | 2005 |
Other Publication | MOLECULAR IMAGING AND BIOLOGY | Comparison between 2-deoxy-2-[F-18]fluoro-D-Glucose positron emission tomography | 2004 |
Other Publication | JOURL OF NUCLEAR MEDICINE | Impact of patient weight and emission scan duration on PET | 2004 |
Other Publication | MOLECULAR IMAGING AND BIOLOGY | Conventiol imaging and 2 | 2004 |
Other Publication | JOURL OF NUCLEAR MEDICINE | Relationship between F-18-FDG uptake and breast density in women with normal breast tissue | 2003 |
Other Publication | CHEST | Value of F-18 fluorodeoxyglucose positron emission tomography for predicting the clinical outcome | 2003 |
Other Publication | Molecular imaging and biology | Conventiol imaging and 2 | 2003 |
Dr. Andrew A Quon, MD has not yet indicated the hospitals that he is affiliated with.
Accepts New Patients: Yes
Dr. Andrew A Quon, MD has not yet listed the medications that he commonly prescribes.
Dr. Andrew A Quon, MD has not yet added any information about his practice's billing policies and payment options.